Anurse is discussing intravenous Amphotericin B treatment with a nursing student who is about to care for a patient with a systemic fungal infection. Which statement by the student indicates a need for further teaching?

Choice A reason:
Alcohol abuse is the leading cause of chronic pancreatitis in many cases. Chronic alcohol consumption leads to repeated episodes of pancreatic inflammation, resulting in fibrosis, loss of pancreatic function, and structural damage. Alcohol directly stimulates pancreatic secretions and contributes to the formation of protein plugs that obstruct pancreatic ducts, exacerbating the condition.
Choice B reason:
Bulimia is not a known contributing factor for chronic pancreatitis. While eating disorders can have gastrointestinal manifestations, they do not directly lead to the chronic inflammatory process seen in pancreatitis.
Choice C reason:
A history of gallstones is a recognized contributing factor to chronic pancreatitis. Gallstones can intermittently block the pancreatic duct, leading to inflammation and damage over time. While gallstones are more commonly associated with acute pancreatitis, they also play a role in the chronic form if untreated or recurrent.
Choice D reason:
Bacterial infection is not a primary contributing factor to chronic pancreatitis. While infections can complicate pancreatic conditions, they do not typically initiate the chronic inflammatory process. Chronic pancreatitis is more often caused by mechanical, toxic, or genetic factors rather than infectious agents.

Choice A reason:
Aspirin is an antiplatelet medication used to prevent blood clots in the arteries but is not the primary treatment for deep vein thrombosis (DVT), which is likely in this scenario. The patient's symptoms suggest a possible DVT, which requires anticoagulation therapy.

Choice B reason:
Clopidogrel (Plavix) is another antiplatelet medication, similar to aspirin, and is not the primary treatment for DVT. It is more commonly used to prevent clotting in arterial diseases such as coronary artery disease but not for venous thromboembolism.

Choice C reason:
Enoxaparin (Lovenox) is a low molecular weight heparin used for the initial treatment of DVT. It is an anticoagulant that helps prevent further clot formation and allows the body to break down the existing clot. Given the patient's symptoms, enoxaparin is the appropriate medication to anticipate for managing DVT.

Choice D reason:
Warfarin (Coumadin) is an oral anticoagulant used for long-term prevention of thromboembolism but is not typically used for initial DVT treatment due to its slow onset of action. Enoxaparin or other forms of heparin are preferred for immediate anticoagulation.